Status:
UNKNOWN
Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Perihilar Cholangiocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Curative treatment of peri hilar cholangiocarcinomas is R0 surgery and require major hepatectomy with biliary tract resection. These complexe procedures can lead to high morbidity and mortality. A sev...
Detailed Description
Peri hilar cholangiocarcinomas are rare tumors, which when diagnosed at the resectable stage, require major hepatic resection associated with biliary reconstruction. These are complex procedures with ...
Eligibility Criteria
Inclusion
- Surgical peri hilar cholangiocarcinoma from 01/01/2003 to 04/01/2021 at Nancy University Hospital
Exclusion
- Non curative surgery
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04846192
Start Date
April 1 2021
End Date
May 1 2021
Last Update
April 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Vandœuvre-lès-Nancy, France, 54500